4.7 Article

Clinical Characteristics of Patients with Pustular Psoriasis: A Single-Center Retrospective Observational Study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Dermatology

Pathophysiology of Generalized Pustular Psoriasis

Slaheddine Marrakchi et al.

Summary: Generalized pustular psoriasis (GPP) is a rare and severe form of the disease, distinct from plaque psoriasis. Dysregulation of the IL-36 signaling pathway appears central to the pathogenesis of GPP. Treatment targeting the IL-36 inflammatory cascade shows promise, although specific therapeutic agents for GPP are currently lacking.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2022)

Review Dermatology

The Prevalence and Disease Characteristics of Generalized Pustular Psoriasis

Min Zheng et al.

Summary: Generalized pustular psoriasis (GPP) is a rare disease that has been historically difficult to diagnose due to a lack of awareness and similarities to other types of psoriasis. Recent research has shown the importance of differentiating GPP from plaque psoriasis, and understanding the genetic characteristics of GPP may improve diagnosis accuracy in the future.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2022)

Article Dermatology

Prevalence and incidence of generalized pustular psoriasis in Sweden: a population-based register study

Sofia Lofvendahl et al.

Summary: This study estimated the prevalence and incidence of generalized pustular psoriasis (GPP) in the Swedish general population, as well as the prevalence of psoriasis vulgaris within the GPP population. The results indicated that the estimated GPP population in Sweden falls within the range of previous estimates, but the estimates were sensitive to the criteria used to define GPP cases.

BRITISH JOURNAL OF DERMATOLOGY (2022)

Article Allergy

Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasis

Patrick Baum et al.

Summary: This study revealed that the IL-36 pathway plays a significant role in the pathogenesis of generalized pustular psoriasis. Treatment with spesolimab, an anti-IL-36 receptor antibody, resulted in rapid improvement of skin and pustular symptoms in patients with GPP. The treatment also modulated dysregulated molecular pathways associated with GPP and PPP, leading to improved clinical outcomes.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Article Dermatology

Clinical characteristics of Japanese pustular psoriasis: A multicenter observational study

Chika Ohata et al.

Summary: Generalized pustular psoriasis (GPP) is a rare and severe subtype of psoriasis that predominantly affects females with lower body mass index and lesser rates of alcohol consumption. The study identified different types of GPP, age at onset, and precipitating factors, shedding light on the demographics and characteristics of patients with GPP.

JOURNAL OF DERMATOLOGY (2022)

Review Dermatology

Role of Interleukin 36 in Generalised Pustular Psoriasis and Beyond

Kazumitsu Sugiura

Summary: Generalised pustular psoriasis (GPP) is a severe skin disease with limited treatment options. Recent research has identified genetic mutations associated with GPP and improved our understanding of the molecular mechanisms involved in inflammation. Interleukin (IL)-36 has been found to play a central role as a cytokine in the development and progression of GPP. This discovery opens up new possibilities for targeted therapeutics.

DERMATOLOGY AND THERAPY (2022)

Article Dermatology

Palmoplantar pustulosis and acrodermatitis continua of Hallopeau: demographic and clinical comparative study in a large multicentre cohort

F. Assan et al.

Summary: Our study compared the epidemiological and clinical characteristics of palmoplantar pustulosis (PPP) and acrodermatitis continua of Hallopeau (ACH). PPP was associated with female sex, smoking activity, and higher body mass index compared to ACH. PPP also had a higher frequency of family history of psoriasis. Both PPP and ACH had similar age of onset for palmoplantar disease. Peripheral joint inflammatory involvement was only associated with ACH. The association with another psoriasis type was similar for both PPP and ACH.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2022)

Article Medicine, General & Internal

Trial of Spesolimab for Generalized Pustular Psoriasis

H. Bachelez et al.

Summary: In a phase 2 randomized trial, spesolimab, an interleukin-36 receptor inhibitor, showed a higher rate of lesion clearance in GPP patients compared to placebo, but was associated with risks of infections and systemic drug reactions. Further longer and larger trials are needed to assess the efficacy and safety of spesolimab in patients with pustular psoriasis.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Biochemistry & Molecular Biology

Pustular Psoriasis: From Pathophysiology to Treatment

Giovanni Genovese et al.

Summary: Pustular psoriasis is a clinicopathological entity with different variants characterized by sterile pustules on an erythematous base, showing intense inflammatory response and involvement of the IL-36 axis. Due to the rarity and heterogeneity of PP forms, data on prognosis and therapeutic management are limited, leading to ongoing debates on the diagnosis and treatment of PP.

BIOMEDICINES (2021)

Article Dermatology

Epidemiology and clinical features of pustular psoriasis: A 15-year retrospective cohort

Theetouch Tosukhowong et al.

Summary: Pustular psoriasis (PuP) is a rare variant of psoriasis, with the most prevalent subtype being Generalized PuP (GPP), often triggered by corticosteroid withdrawal, upper respiratory tract infection, and pregnancy. Treatment mainly involves oral acitretin and topical corticosteroids.

JOURNAL OF DERMATOLOGY (2021)

Article Dermatology

Patient characteristics and burden of disease in Japanese patients with generalized pustular psoriasis: Results from the Medical Data Vision claims database

Akimichi Morita et al.

Summary: Generalized pustular psoriasis (GPP) is a rare and severe systemic, neutrophilic skin disease. This study in Japan showed that patients with GPP have a higher burden of illness compared to those with plaque psoriasis, including higher prevalence of comorbidities, different medication use, and increased healthcare resource utilization.

JOURNAL OF DERMATOLOGY (2021)

Article Biochemistry & Molecular Biology

Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database

Stephanie Nguengang Wakap et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2020)

Article Allergy

Clinical and genetic differences between pustular psoriasis subtypes

Sophie Twelves et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)

Review Dermatology

Pustular psoriasis and related pustular skin diseases

H. Bachelez

BRITISH JOURNAL OF DERMATOLOGY (2018)

Review Dermatology

European consensus statement on phenotypes of pustular psoriasis

A. A. Navarini et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)

Article Dermatology

Clinical features and course of generalized pustular psoriasis in Korea

Hyunju Jin et al.

JOURNAL OF DERMATOLOGY (2015)

Article Dermatology

Clinical and Laboratory Features in Acute Generalized Pustular Psoriasis A Retrospective Study of 34 Patients

Joao Borges-Costa et al.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2011)